UPDATED Jun 23, 2024
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LLY | US$883.88 | -0.1% | 95.2% | US$795.9b | US$855.39 | PE129.7x | E27.3% | 0.6% | ||
NOVO B | kr.988.40 | 0.8% | 83.9% | kr.4.4t | kr.934.27 | PE49.1x | E13.3% | 1.0% | ||
JNJ | US$148.75 | 2.2% | -10.1% | US$358.0b | US$171.72 | PE21x | S4.4% | 3.3% | ||
MRK | US$130.72 | 2.5% | 15.6% | US$331.1b | US$142.68 | PE143.6x | E23.7% | 2.4% | ||
ABBV | US$170.39 | 1.1% | 25.4% | US$300.9b | US$183.24 | PE50.6x | E23.0% | 3.6% | ||
AZN | UK£124.72 | 0.4% | 10.4% | UK£193.3b | UK£136.65 | PE38.7x | E14.7% | 2.0% | ||
ROG | CHF252.80 | 3.0% | -7.4% | CHF204.0b | CHF278.05 | PE17.5x | E8.6% | 3.8% | ||
TMO | US$564.60 | -0.6% | 8.2% | US$215.5b | US$629.47 | PE35.7x | E10.6% | 0.3% | ||
NOVN | CHF93.99 | 0.5% | 5.7% | CHF191.8b | CHF98.65 | PE23.6x | E10.2% | 3.4% | ||
DHR | US$254.96 | 0.3% | 7.2% | US$188.8b | US$273.31 | PE46.4x | E13.8% | 0.4% | ||
PFE | US$27.74 | 2.8% | -24.8% | US$157.2b | US$31.92 | PS2.9x | E30.6% | 6.1% | ||
VRTX | US$468.71 | -1.1% | 34.9% | US$121.0b | US$463.42 | PE30.1x | E10.4% | n/a | ||
SAN | €87.62 | -0.06% | -10.4% | €109.5b | €108.19 | PE24.1x | E17.0% | 4.3% | ||
REGN | US$1,053.14 | 0.7% | 34.3% | US$113.6b | US$1,051.47 | PE29.5x | E12.5% | n/a | ||
CSL | AU$292.01 | 1.1% | 4.3% | AU$141.6b | AU$307.59 | PE37.9x | E14.7% | 1.2% | ||
GILD | US$70.67 | 10.0% | -7.7% | US$88.0b | US$82.89 | PE181.5x | E36.2% | 4.4% | ||
BMY | US$41.93 | 2.3% | -35.3% | US$85.0b | US$53.19 | PS1.9x | E44.7% | 5.7% | ||
GSK | UK£15.99 | -0.06% | 12.6% | UK£65.2b | UK£20.36 | PE14.5x | E12.4% | 3.6% | ||
ZTS | US$171.09 | 0.1% | 2.1% | US$78.1b | US$210.15 | PE32.7x | E8.6% | 1.0% | ||
MRK | €166.75 | -2.6% | 9.3% | €72.5b | €186.06 | PE26.6x | E11.3% | 1.3% | ||
4568 | JP¥5,442.00 | 0.8% | 18.4% | JP¥10.4t | JP¥6,176.67 | PE51.8x | E20.8% | 1.1% | ||
4519 | JP¥5,358.00 | 8.4% | 27.6% | JP¥8.5t | JP¥5,932.14 | PE27x | E5.3% | 1.5% | ||
MRNA | US$133.40 | -3.3% | 10.8% | US$51.1b | US$145.85 | PS9.9x | E67.4% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a |